Expression and function of ABCG2 and XIAP in glioblastomas
- 21 April 2017
- journal article
- laboratory investigation
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 133 (1) , 47-57
Abstract
Despite multimodal treatment that includes surgery, radiation and chemotherapy, virtually all glioblastomas (GBM) recur, indicating that these interventions are insufficient to eradicate all malignant cells. To identify potential new therapeutic targets in GBMs, we examined the expression and function of proteins that are associated with therapy resistance and cancer cell survival. We measured the expression of eight such proteins in 50 GBM samples by immunohistochemistry and analyzed patient survival. We report that GBM patients with high expression of ABCG2 (also called BCRP) or XIAP at the protein level had worse survival than those with low expression. The adjusted hazard ratio for ABCG2 was 2.35 and for XIAP was 2.65. Since glioma stem cells (GSCs) have been shown to be more resistant than bulk tumor cells to anti-cancer therapies and to express high levels of these proteins, we also sought to determine if ABCG2 and XIAP have functional roles in GSCs. We used small molecule inhibitors to treat patient-derived GBM tumorspheres in vitro and observed that inhibitors of ABCG2, Ko143 and fumitremorgin, significantly reduced self-renewal. These results suggest that ABCG2 and XIAP proteins may be useful indicators of patient survival and that inhibition of ABCG2 may be a promising therapeutic strategy in GBMs.Keywords
Funding Information
- Northern New England Clinical Oncology Society
- Schering-Plough (XX-3903)
- Maine Medical Center Research Institute
- Donaldson Charitable Trust
This publication has 36 references indexed in Scilit:
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- Emerging role of Notch in stem cells and cancerCancer Letters, 2009
- PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like CellsCell Stem Cell, 2009
- Cancer Stem Cells Are Enriched in the Side Population Cells in a Mouse Model of GliomaCancer Research, 2008
- Cancer stem cells and survival pathwaysCell Cycle, 2008
- A Phase I, Randomized, Open-Label, Parallel-Cohort, Dose-Finding Study of Elacridar (GF120918) and Oral Topotecan in Cancer PatientsClinical Cancer Research, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- ROLE OF ABCG2/BCRP IN BIOLOGY AND MEDICINEAnnual Review of Pharmacology and Toxicology, 2006
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.Journal of Experimental Medicine, 1996